Yongin, Ch'ungch'ong-namdo, South Korea In 1967 was created Green Cross, which is appeared as Corporate Investor. The company was established in Asia in South Korea. The leading representative office of defined Corporate Investor is situated in the Yongin.
The important activity for fund was in 2018. The real fund results show that this Corporate Investor is 5 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Green Cross, startups are often financed by Triathlon Medical Venture Partners, SparkLabs Accelerator, Early Stage Partners. The meaningful sponsors for the fund in investment in the same round are Tong Yang Venture Capital, Smilegate Investment, SBI Investment.
The fund has no exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Artificial Intelligence, Genetics. Among the most popular portfolio startups of the fund, we may highlight Juventas Therapeutics, PharmAbcine, Genoplan. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
| Fund Name | Location |
| Caballeros Capital | - |
| Catalysta Partners | Georgia, Roswell, United States |
| DPI Energy Ventures | - |
| Fletcher Spaght, Inc. | Boston, Massachusetts, United States |
| Fountain Capital | China, Guangdong, Shenzhen |
| Innovent | California, United States, Walnut Creek |
| Keystone Capital Partners | New York, New York, United States |
| Leyu Tianqi Culture Communication | Beijing, Beijing, China |
| McWin | - |
| Meiya Pico | China, Fujian, Xiamen |
| North First Ventures | Israel, Tel Aviv, Tel Aviv District |
| Steltec Capital | - |
| Stream Global Services | Eagan, Minnesota, United States |
| Techstars Ventures | Boulder, Colorado, United States |
| United Investments | New Taipei, Taiwan |
| Wasu Media Holding | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Kanaph Therapeutics | $21M | 12 Oct 2020 | South Korea | ||
GeneCast | $12M | 08 Jun 2020 | South Korea, Gyeonggi-do, South Korea | ||
Doing Lab | $1M | 31 May 2020 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
Vuno | $12M | 20 Nov 2018 | South Korea | ||
Genoplan | $13M | 29 Jun 2018 | New York, New York, United States | ||
Juventas Therapeutics | $13M | 12 May 2015 | Cleveland, Ohio, United States | ||
PharmAbcine | $6M | 16 Sep 2009 | South Korea, Gyeonggi-do, South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Kanaph Therapeutics | $21M | 12 Oct 2020 | South Korea | ||
GeneCast | $12M | 08 Jun 2020 | South Korea, Gyeonggi-do, South Korea | ||
Doing Lab | $1M | 31 May 2020 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
Vuno | $12M | 20 Nov 2018 | South Korea | ||
Genoplan | $13M | 29 Jun 2018 | New York, New York, United States | ||
Juventas Therapeutics | $13M | 12 May 2015 | Cleveland, Ohio, United States | ||
PharmAbcine | $6M | 16 Sep 2009 | South Korea, Gyeonggi-do, South Korea |
